On the optimal treatment of Metallo-Beta-Lactamase-producing Enterobacterales infections using aztreonam and avibactam.

IF 8.2 1区医学 Q1 IMMUNOLOGY

Clinical Infectious Diseases Pub Date : 2025-05-12 DOI:10.1093/cid/ciaf240

Yehuda Carmeli,José Miguel Cisneros,Mical Paul,Joseph Chow,George L Daikos

引用次数: 0

查看原文本刊更多论文

氨曲南与阿维巴坦治疗产金属内酰胺酶肠杆菌感染的最佳研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Infectious Diseases 医学-传染病学

CiteScore

25.00

自引率

2.50%

发文量

900

审稿时长

3 months

期刊介绍： Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.